Crossmark

Inositol pyrophosphates and Akt/PKB: Is the pancreatic β-cell the exception to the rule?

Crossref DOI link: https://doi.org/10.1016/j.cellsig.2019.02.003

Published Print: 2019-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kim, Jaeyoon

Darè, Elisabetta

Rajasekaran, Subu Surendran

Ryu, Sung Ho https://orcid.org/0000-0003-0913-3048
Berggren, Per-Olof

Barker, Christopher J.
Funding

Funding for this research was provided by:

Swedish Research Council

Novo Nordisk Foundation

Karolinska Institutet

Swedish Diabetes Association

The Family Knut and Alice Wallenberg Foundation

Diabetes Research and Wellness Foundation

Swedish Foundation for Strategic Research

Berth von Kantzow's Foundation

The Skandia Insurance Company Ltd.

Karolinska Institutet

Stichting af Jochnick Foundation

Family Erling-Persson Foundation

STINT

National Research Foundation of Korea (NRF-2016K1A1A2912722)

National Research Foundation of Korea (NRF-2018R1A6A3A11046983)

Korea Government
License Information

Text and Data Mining valid from 2019-06-01

Text and Data Mining valid from 2019-06-01

Version of Record valid from 2019-03-13
More Information

This article is maintained by: Elsevier

Article Title: Inositol pyrophosphates and Akt/PKB: Is the pancreatic β-cell the exception to the rule?

Journal Title: Cellular Signalling

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cellsig.2019.02.003

Content Type: article

Copyright: © 2019 The Authors. Published by Elsevier Inc.